COVID-19
TOOLBOX
Filter
133
Featured
Language
Document type
Fact sheets
44
Guidelines
44
Studies & Reports
14
Resource Platforms
11
Manuals
7
Infographics
5
Situation Updates
4
Videos
3
Training Material
1
Countries / Regions
Germany
17
Russia
8
Brazil
8
India
6
West and Central Africa
6
Argentina
6
East and Southern Africa
6
Mozambique
3
Africa
3
South Sudan
2
Latin America and the Carribbean
2
Middle East and North Africa
2
Western and Central Europe
2
Belarus
1
Angola
1
Vietnam
1
Turkey
1
South Korea
1
Spain
1
Portugal
1
Kazakhstan
1
France
1
Guinea-Bissau
1
Haiti
1
Global
1
United Kingdom
1
Authors & Publishers
World Health Organization WHO
51
Africa CDC Centres for Disease Control and Prevention
12
African Union
12
Robert-Koch-Institut RKI
7
Ministerio de Salud Argentina
6
European Medicines Agency EMA
5
Organisation Mondiale de la Santé OMS
5
OPAS
4
World Health Organization WHO, Regional Office of Europe
4
World Health Organization WHO, et al.
4
Organización Mundial de la Salud OMS
3
Dirección de Control de Enfermedades Inmunoprevenibles
3
OPAS, OMS
2
Pan American Health Organisation PAHO
2
Paul Ehrlich Institute
2
Feraud, H.
2
World Health Organisation (WHO)
2
Organización Mundial de Saude and OPAS
2
Deutsches Grünes Kreuz e. V., Marburg, Robert Koch-Institut RKI
2
Organização Mundial da Saúde (OMS)
1
Bayerisches Staatsministerium für Gesundheit und Pflege
1
Pfizer
1
Polack, F.P. et al.
1
Bharat Biotech
1
Robert-Koch-Instiut RKI
1
S.R. Lewin and R. Sherer
1
TASS russian news agency
1
The Gamaleya National Center Russia
1
Vaccine Centre at the London School of Hygiene & Tropical Medicine
1
Vygen-Bonnet S, Koch J, Bogdan C, et al.
1
and C. Wonodi
1
World Health Organization WHO, SAGE
1
Zimmer, C, J. Corum and S. Wee
1
UNICEF
1
New York Times
1
Organización Mundial de la Salud
1
Kamradt, T., and B.S. Kamps
1
Camp, R. and C. Hoffmann
1
CDC
1
Clinical Care Options
1
Coision Nacional de Seguridad en Vacunas
1
Food and Drug Administration
1
Gesellschaft für Thrombose-undHämostaseforschung e.V. GTH
1
Greinacher, A., et al.
1
Harding-Zentrum für Risikokompetenz
1
Kamps, B.S.
1
Kamradt, T., B.S. Kamps J. García-Rosales Delgado
1
BioNTech
1
Kim, A.
1
Knoll, M.D.
1
Logunov, D.Y, et al.
1
Mauder, S.
1
Mauder, S., K. Geffert
1
MEDBOX
1
Medicines and Healthcare products Regulatory Agency (MHRA) UK
1
BBC
1
New England Journal of Medicine
1
Всемирная организация здравоохранения
1
Publication Years
Category
COVID-19
53
Guidelines
11
Information, Education and Communication (IEC)
7
Studies & Reports
4
x MEDBOX Issue Brief & Annual Reports x
2
Women & Child Health
2
Countries
1
Policies
1
Immunization
1
Toolboxes
Vaxzevria (Astra Zeneca)
26
Research & Pipeline
26
Biontech/Pfizer Comirnaty
23
Inactivated COVID-19 Vaccines
18
mRna Vaccines general
15
Vector-based Vacines General
14
Moderna
13
Country specific documents
12
Communication Material
11
COVID-19 Vaccination Information
10
COVID-19 Vaccination
10
Immunization Guidelines
9
Johnson & Johnson
8
Scientific & Research Studies
8
Vaccine Candidates & Research
8
Dashboards & Resource Platforms
7
Covaxin
6
Logistics & Supply
6
For Migrants & Refugees
5
For Older People
5
SARS-CoV-2 Variants
4
Videos
4
Sputnik V
3
Access & Strategy
3
Booster Doses
2
Vaccination
2
For Health Worker
2
Training, others
2
Prevention & Preparedness
2
Anamnesis / Screening
2
Non-pharmaceutical interventions (NPIs)
1
Pediatrics
1
Vaccination & Strategy
1
Essential Medicines & Medical Devices
1
For Parents & Children
1
For General Public & Community
1
COVID-19
1
COVID-19 Information
1
Public Health
1
Clinical Aspects
1
Clinical Guidelines
1
Pharmacovigilance
1
The COVID-19 vaccine tracker and landscape compiles detailed information of each COVID-19 vaccine candidate in development by closely monitoring their progress through the pipeline. The COVID-19 vaccine tracker: Provides summary tables of COVID-19 vaccine candidates in both clinical and pre-... more
Aktualisiertung19.10.2021. Der Aufklärungsbogen in einfacher Sprache kann in zahlreichen weiteren Sprachen heruntergeladen werden kann: Albanisch, Arabisch,Bulgarisch, Dari, Englisch, Französisch, Kroatisch, Pashtu, Persisch, Polnisch, Rumänisch, Russisch, Serbisch, Spanisch, Tigrinisch, Türkisc... more
6 June 2022 These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below. Th... more
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method... more
orientaciones provisionales, primera publicación: 24 de mayo de 2021, actualización: 21 de octubre de 2021, actualización: 15 de marzo de 2022
Временное руководство (‎Первый выпуск 24 мая 2021 г., Обновлено 21 октября 2021 г., Обновлено 15 марта 2022 г.
This chronology of facts has challenged public health systems worldwide and regulatory bodies are no exception. Regulatory authorities with mechanisms in place to authorize the use of investigational products had to development guidelines and procedures, create task forces and alliances to maximize ... more
27 September 2022 These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
29 April 2022 What are the new vaccines in the pipeline? What are the challenges to turning vaccines into vaccination ? What timelines can we expect for future vaccines? WHO’s Dr Katherine O’Brien explains in Science in 5.
Los datos preliminares de eficacia se infirieron mediante un enfoque de “inmunogenicidad puente”, en el que los títulos neutralizantes obtenidos después de la vacuna en niños y niñas de 5 a 11 años se compararon con los títulos obtenidos en adolescentes de 16 a 25 años (en quienes se hab... more
El siguiente manual se continuará actualizando, de ser necesario, a medida que se disponga de nueva información.
CONVIDECIA is based on a modified human adenovirus that expresses the spike S protein of SARS-CoV-2. It is administered as a single dose.
mRNA technologies. What is their future and scope, and what are the challenges that countries might face in rolling them out? Hello and welcome to Science in5. I'm Vismita Gupta-Smith. We are talking to Dr.Soumya Swaminathan today. Soumya, talk to us about mRNA technologies. What is the future?
Declarations of interests were collected from all external contributors and assessed for any conflicts of interest. Summaries of the reported interests can be found on the SAGE meeting website and SAGE Covid-19 Working Group webpage. This guidance should be considered along with the broader COVID-... more
Organización Mundial de la Salud. (‎2022)‎. Recomendaciones provisionales sobre el uso de la vacuna CanSinoBIO Ad5-nCoV-S [‎recombinante]‎ (‎Convidecia™)‎ contra la COVID-19: orientaciones provisionales, primera publicación: 19 de mayo de 2022.